Science Policy Should Be Independent Of Political And Ideological Concerns

A half-century ago, United States Gen. George V. Strong wrote a letter denying Albert Einstein a security clearance to work on the Manhattan Project. The general apparently based his decision on allegations that the physicist was an "extreme radical" and would be a security risk. He was neither of these. Nevertheless, he was at the center of the most striking effort to smuggle ideology into science in U.S. history. Unfortunately, the practice seems to persist. The Bush administration last year

Written byKenneth Goodman
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

A half-century ago, United States Gen. George V. Strong wrote a letter denying Albert Einstein a security clearance to work on the Manhattan Project. The general apparently based his decision on allegations that the physicist was an "extreme radical" and would be a security risk. He was neither of these. Nevertheless, he was at the center of the most striking effort to smuggle ideology into science in U.S. history. Unfortunately, the practice seems to persist.

The Bush administration last year indefinitely extended a ban on federal financial support for experiments using fetal tissue. Use of the tissue, obtained from elective abortions, was strongly opposed by antiabortion groups. Those who support the research suggest that the investigations could advance the treatment of diabetes and Parkinson's and Alzheimer's diseases.

The decision by the Department of Health and Human Services (HHS) has been criticized as ideologically motivated, and it is. What is common ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies